Skip to main content

Anna Marcé Grau

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Anna Marcé Grau

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Projects

Enfermedades minoritarias causantes de degeneración de ganglios basales en pedriatría: implemementación combinada del análisis genómico y de biomarcadores.

IP: Belen Perez Dueñas
Collaborators: José Antonio Arranz Amo, Josefa Élida Vázquez Méndez, Alfons Macaya Ruíz, Anna Marcé Grau, Clara Carnicer Cáceres, Mireia Del Toro Riera, Ana Felipe Rucián, Amaia Lasa Aranzasti
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI18/01319
Duration: 01/01/2019 - 31/12/2022

Exoma diagnóstico, exoma de investigación y genoma completo: maximizando el rendimiento de la secuenciación masiva en las encefalopatís epilépticas precoces

IP: Alfons Macaya Ruíz
Collaborators: Anna Marcé Grau, Miquel Raspall Chaure
Funding agency: Instituto de Salud Carlos III
Funding: 140965
Reference: PI15/01791
Duration: 01/01/2016 - 30/11/2020

Neurologia Pediàtrica (GRC)

IP: Alfons Macaya Ruíz
Collaborators: Susana Boronat Guerero, Francina Munell Casadesus, Neurologia Pediàtrica (GRC), Anna Marcé Grau, Miquel Raspall Chaure, Mireia Del Toro Riera, Marta Vila Pueyo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1087
Duration: 01/01/2014 - 31/12/2016

Secuenciación exómica en el estudio molecular de las encefalopatías epilépticas de inicio precoz

IP: Alfons Macaya Ruíz
Collaborators: Anna Marcé Grau
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-2014-2
Duration: 16/02/2015 - 15/02/2018

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

Related professionals

Cristina Márquez González

Cristina Márquez González

Research technician
Stroke research
Read more
Carles Zafon Llopis

Carles Zafon Llopis

Main researcher
Diabetes and Metabolism
Read more
Sílvia Ripollés Nze

Sílvia Ripollés Nze

Gestió i Administració
Unitat legal
Legal Directorate
Read more
Elisabet Jiménez Molina

Elisabet Jiménez Molina

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.